logo

IKT

Inhibikase·NASDAQ
--
--(--)
--
--(--)

IKT fundamentals

Inhibikase (IKT) released its earnings on Aug 14, 2025: revenue was -- (YoY --), beat estimates; EPS was -0.11 (YoY +83.33%), missed estimates.
Revenue / YoY
--
--
EPS / YoY
-0.11
+83.33%
Report date
Aug 14, 2025

Earnings

EPS
Revenue

Revenue & Expenses

Key Indicators

Inhibikase (IKT) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Inhibikase (IKT)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown

Balance Sheet

Inhibikase (IKT)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown

Cash Flow

Inhibikase (IKT)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown

Revenue Breakdown

Where does Inhibikase (IKT) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:

Dividend

Track Inhibikase (IKT) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield